The effects of sodium hyaluronate, chondroitin sulfate, and methylcellulose on the corneal endothelium and intraocular pressure

American Journal of Ophthalmology
S M Mac RaeR O Schultz

Abstract

Sodium hyaluronate (Healon), chondroitin sulfate, and methylcellulose have been used to protect the corneal endothelium from intraocular lens trauma. A study of the efficacy and toxicity of these compounds showed that 1% sodium hyaluronate, 0.4% methylcellulose, and 20% chondroitin sulfate were nontoxic to the corneal endothelium, but that 20% chondroitin sulfate caused a marked decrease in corneal thickness because of its hypertonicity. Anterior chamber injection of these viscous substances resulted in an increase in intraocular pressure. Within one to four hours the maximum intraocular pressure with 1% sodium hyaluronate was 67 +/- 4.1 mm Hg and that with 20% chondroitin sulfate was 55 +/- 3.5 mm Hg. The intraocular pressure did not increase to these high levels with 10% chondroitin sulfate or 0.4% methylcellulose or when the test substances were washed out of the anterior chamber. The corneal endothelium was protected from injury with 1% sodium hyaluronate and 20% chondroitin sulfate, but 10% chondroitin sulfate and 0.4% methylcellulose provided only minimal protection.

References

Apr 1, 1979·Journal - American Intra-Ocular Implant Society·P M Knight, W J Link
Oct 1, 1978·American Journal of Ophthalmology·N Rosen, M Lazar
Aug 1, 1985·The British Journal of Ophthalmology·M S PassoT K Goldstick
Jul 1, 1980·Journal - American Intra-Ocular Implant Society·D B SollT Clinch
May 1, 1982·Archives of Ophthalmology·K J Hoffer
Jul 1, 1980·Ophthalmology·L G Pape, E A Balazs
Jul 1, 1981·Archives of Ophthalmology·H F EdelhauserD L Van Horn
Jul 1, 1980·Experimental Eye Research·E L GraueE A Balazs
Oct 1, 1980·Journal - American Intra-Ocular Implant Society·L G Pape
Feb 1, 1980·The Western Journal of Medicine·F T Fraunfelder

❮ Previous
Next ❯

Citations

Sep 15, 1985·American Journal of Ophthalmology·B A BarronH E Kaufman
Jan 8, 2004·Journal of Cataract and Refractive Surgery·John M KatsimprisNikolaos Georgiadis
Aug 1, 1992·Australian and New Zealand Journal of Ophthalmology·M D Zhu, F Y Cai
Jan 1, 1984·Journal - American Intra-Ocular Implant Society·S G SmithE Mindrup
Mar 1, 1985·Journal - American Intra-Ocular Implant Society·L L Civerchia, A Balent
Sep 1, 1985·Journal - American Intra-Ocular Implant Society·E Olivius, W Thorburn
Apr 1, 1986·Ophthalmology·C Teekhasaenee, R Ritch
Jul 1, 1989·Journal of Cataract and Refractive Surgery·L L Fry
May 1, 1993·Journal of Cataract and Refractive Surgery·L L Fry, R W Yee
Nov 1, 1993·Journal of Cataract and Refractive Surgery·L E Probst, B D Nichols
Jul 11, 1991·Journal of Cataract and Refractive Surgery·S Kwitko, R Belfort
Apr 1, 1997·Journal of Cataract and Refractive Surgery·G RavalicoA Lovisato
Mar 1, 1995·Journal of Cataract and Refractive Surgery·J ColinJ P Romanet
Jul 1, 1997·Journal of Cataract and Refractive Surgery·P C JacobiG K Krieglstein
Sep 1, 1991·Survey of Ophthalmology·K F Tomey, C E Traverso
Jan 1, 1990·Survey of Ophthalmology·T J Liesegang
Aug 1, 1987·Australian and New Zealand Journal of Ophthalmology·P A RosenW E Gillies
Aug 15, 1984·American Journal of Ophthalmology·G Barrett, I J Constable
Apr 11, 2000·Journal of Biomedical Materials Research·S EinmahlR Gurny
Jun 25, 1998·Journal of Biomedical Materials Research·M T SantiniR Perilli
Jan 1, 1990·Eye·S J Tuft, D J Coster
Aug 1, 1985·The British Journal of Ophthalmology·M S PassoT K Goldstick
Jan 15, 1986·Documenta Ophthalmologica. Advances in Ophthalmology·R Koster, J S Stilma
May 1, 1989·Journal of Cataract and Refractive Surgery·B Roberts, R L Peiffer
Jul 5, 2003·Journal of Cataract and Refractive Surgery·Francesco BosciaCarlo Sborgia
Oct 18, 2000·Journal of Cataract and Refractive Surgery·E A Davis, R L Lindstrom
Nov 1, 1995·Journal of Cataract and Refractive Surgery·T KondoA Nakatsu
Mar 1, 1992·Journal of Cataract and Refractive Surgery·A GuptaS P Grewal
Jun 27, 1998·Journal of Cataract and Refractive Surgery·S A Arshinoff, I Hofman
Mar 1, 1994·Journal of Cataract and Refractive Surgery·L E ProbstB D Nichols
Jun 1, 1997·Journal of Cataract and Refractive Surgery·S A Arshinoff, I Hofmann
Jun 1, 1993·Acta Ophthalmologica·B M Calissendorff, H Hamberg-Nyström
Apr 1, 1997·Acta Ophthalmologica Scandinavica·S N ZhuG Duncker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.